Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B
Open Access
- 13 May 2022
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2022.00066
Abstract
The impact of nonalcoholic fatty liver disease (NAFLD) on the treatment outcome of chronic hepatitis B (CHB) is undefined and deserves an in-depth investigation.Keywords
This publication has 32 references indexed in Scilit:
- Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavirTurkish Journal of Gastroenterology, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesJournal of Hepatology, 2015
- Saturated Fatty Acid Inhibits Viral Replication in Chronic Hepatitis B Virus Infection With Nonalcoholic Fatty Liver Disease by Toll-Like Receptor 4-Mediated Innate Immune ResponseHepatitis Monthly, 2015
- Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitorsJournal of Hepatology, 2014
- On-Treatment Low Serum HBV RNA Level Predicts Initial Virological Response in Chronic Hepatitis B Patients Receiving Nucleoside Analogue TherapyAntiviral Therapy, 2014
- Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: New light on an old paradoxJournal of Hepatology, 2013
- Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis BPLOS ONE, 2012
- Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factorsEuropean Journal of Gastroenterology & Hepatology, 2009
- Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non‐alcoholic steatohepatitisAlimentary Pharmacology & Therapeutics, 2007
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006